DeNovaMed Wins I-3 Contest
There’s a new star in the constellation of Atlantic Canadian startups – DeNovaMed Inc.
The Halifax biotech, which is developing a new class of compounds to battle superbug viruses, was awarded the top prize Wednesday in Innovacorp’s I-3 competition, beating out 141 competitors from across Nova Scotia.
The company, which grew out of the research lab at the IWK children’s hospital, has used computer-aided drug design to develop a new class of antibiotics to treat infections caused by drug-resistant bacteria, known as superbugs. These superbugs have proliferated greatly in the last 30